J. Boudreault

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

P. Chevallier, P. Moreau, A. Moreau, 2017, Annals of Hematology.

Testing Mayo Clinic’s New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study

M. Pavic, Camille Tessier, J. Boudreault, 2021, Current oncology.

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

G. Sauvageau, S. Landais, D. Ogez, 2021, Bone Marrow Transplantation.

The role of SLAMF7 in multiple myeloma: impact on therapy

P. Moreau, C. Touzeau, J. Boudreault, 2017, Expert review of clinical immunology.

Evaluation of subcutaneous rituximab administration on Canadian systemic therapy suites.

D. Stewart, B. Maturi, J. Boudreault, 2018, Current oncology.

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

M. Amiot, P. Moreau, C. Touzeau, 2017, Haematologica.

Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials

P. Moreau, C. Touzeau, J. Boudreault, 2017, Expert review of hematology.

Bendamustine-induced nephrogenic diabetes insipidus – A case report

Xue Feng, J. Rioux, J. Boudreault, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Single-center retrospective study assessing the efficacy and safety of BeEAM (bendamustine, etoposide, cytarabine, melphalan) as conditioning regimen for autologous hematopoietic stem cell transplantation

J. Boudreault, Xue Feng, Marie-Élaine Plante, 2023, Leukemia & lymphoma.

Efficacy and Safety of Bendamustine-Rituximab as Frontline Therapy for Indolent Non-Hodgkin Lymphoma: A Real-World, Single-Center, Retrospective Study

Jean-Nicolas Champagne, J. Boudreault, Tevy Chan, 2024, Cureus.